Hôpital Européen Georges-Pompidou-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2014

  1. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

    AIDS, Vol. 28, Núm. 16, pp. 2461-2473

2009

  1. Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal

    Clinical Infectious Diseases, Vol. 48, Núm. 8, pp. 1138-1151

2007

  1. Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

    Journal of Acquired Immune Deficiency Syndromes, Vol. 46, Núm. 5, pp. 607-615

2005

  1. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America

    Clinical Infectious Diseases, Vol. 41, Núm. 12, pp. 1772-1782